Back to search

Revance Therapeutics Ltd

08004150

active
Private Limited Company
england wales
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk

No risk factors detected.

Details

19TH FLOOR, LONDON, EC3M 7DQ
Incorporated 23/03/2012

Compliance

Last accounts

31/03/2025

dormant

Next accounts due

31/12/2026

On track

Confirmation statement

Last: 23/03/2026

Due 06/04/2027

On track

Industry

82990
Other business support service activities

Officers

Mufg Corporate Governance Limited

secretary · Since 09/12/2013

BRITISH

Also on 234 other boards

Mr Jeffery A. Bedard

director · Since 06/02/2025

CEO

AMERICAN · UNITED STATES · Age 65

Persons with Significant Control

Revance Therapeutics, Inc.

75–100% shares
75–100% votes
Appoint directors

1222, Demonbreun St, Nashville, TN 37203

Reg: 3074007 · Delawere Department Of State Division Of Corporations · Limited By Shares

Notified 06/04/2016

CompanyRankvs 133653+ SIC 82990 peers
34

Financial strength19th percentile among SIC peers · 5/25
Employees0th percentile among SIC peers · 0/15
LiquidityNo balance sheet data · 0/20
Longevity14 years trading (max 15) · 14/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength5/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees0/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity0/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity14/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/03/2025

Net Worth

£1

Balance sheet strength

Cash

£1

Cash in the bank

Net Current Assets

Working capital

Current Assets

Current Liabilities

Prepared with Companies House